Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4,744.15% | -5.78% | -11.44% | 1.01% | 9.63% |
| Total Depreciation and Amortization | 146.91% | -4.62% | 1.65% | -2.07% | -7.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47,280.73% | 8.93% | -15.73% | -5.20% | 5.66% |
| Change in Net Operating Assets | 275.47% | -193.68% | 2,944.44% | -107.03% | 134.17% |
| Cash from Operations | -13.26% | -29.10% | -3.34% | -6.58% | 28.29% |
| Capital Expenditure | 34.20% | -220.83% | -111.76% | -277.78% | 92.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00% | -- | -- | -100.00% | 20.21% |
| Cash from Investing | 380.87% | -219.44% | -111.76% | -100.06% | 20.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 50,027.03% | 455.00% | -92.81% |
| Repurchase of Common Stock | 41.82% | -83.33% | 57.14% | -37.25% | 71.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 31,860.44% | 76.30% | -- | -- | -- |
| Cash from Financing | 28,988.61% | -101.14% | 129,865.85% | 232.26% | -132.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 540.50% | -209.44% | 225.23% | -174.82% | 128.70% |